{"ticker": {"uuid": "dfe56e32-81f8-4afe-ad4b-c7fd114234a5", "symbol": "TLX", "name": "Telix Pharmaceuticals Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Is Telix Pharmaceuticals (ASX:TLX) the ASX Mid-Cap Health Leader?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPT3dwZklSTXJqNUd2YW9mOXM2d0taMXQyU3JYdHd5TWI1TzNMN0VWbUVfSDNZMnFfZEpHWnMxOE1RTVktQlUxS3NOMUdOdHVWcUpjaHdfcHoyMlotZ283eXp1bXhhRk53QlVSdk9rUy1yTUd0RmN6ZDlXNG9pSEJQcjlNVjF1M0tRZEN2T2k3TWMxbHFwYU9PUTVYY2p0eU9sSGg4SmdR?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-22T06:42:00+00:00", "published_display": "22 Jun 2026 06:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Telix (ASX:TLX) Using Theranostic Alliances To Deepen Its Neuro-Oncology Moat?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-21T09:23:45+00:00", "published_display": "21 Jun 2026 09:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (TLX), United Imaging Healthcare Form Strategic Theranostics Research Partnership", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Insider Monkey", "published_at": "2026-06-17T19:43:19+00:00", "published_display": "17 Jun 2026 19:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Limited Stock 12\u2011Month Price Target Raised to $17.27, Implies 80% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTDRkMXVMTzRlcW1YSnMyMDI3ZGpRTWNJejc0UXNwTGVDN04yWURiTmpsaTlLWHB1NGxNTHFLaU5wRVNqY2RNWktpWHl1TllaODdpRjJFWEI1a0hPTjBvd3N3aU8xUzJwUEQ3bldyeEFlTF9XZmdQVTJIWHFTWEFKa0dVY3lpc0NEX25EMkJpNlNlYkNXcjRsdDF1LUdLaXBnSWhmMTcwSlFfeVAzU05BcktGbHVVMzZRYk1STTRwbTJGeGVVdXpLd0hpQzNqd2h2RVZCTnA4V3VCNmd1RmJsOWpINVo1RHFP?oc=5", "source_name": "TradingView", "published_at": "2026-06-17T04:20:00+00:00", "published_display": "17 Jun 2026 04:20", "sentiment": "positive", "sentiment_pct": 80, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (ASX:TLX) Shares Valuation After New Theranostics Collaboration With United Imaging", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-16T00:32:53+00:00", "published_display": "16 Jun 2026 00:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Prediction: I think Telix shares could double in value in 2026. Here\u2019s why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNZmRVcnhSbmJLQVVtN2dSX2FvemtLS0hRTVNiMDFxVVlwcDRrMXIxbDZEMFNtTk11djlTSnVtOUQxM3dfSXBwU01vRXVsb2tnWEtFRllUa09WNi1DT1N5VEx4dDhxNndzVkJhVnJVX3JtcElQU3hqdmxTQ3ZiYXVHckhLVUZMYmhfUkFFdUZiYS1NWWhVSE1kZU82cGtsYmRfWUJrVFpTX3NJUGM?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (ASX:TLX): Is This ASX Biotech Stock a Buy Opportunity", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPcEwzaFlTZ19yUkx2OVJMYVlNQzdtSVNWZTdsLWxTV3dMNk5WTkFETlNoaDFGaXFZSjR2SWFYN2JIV3FkUG5WOWhmbzVGalZVbTJIdmlhdWwyQWF5QlBmYjZuUUdBX0Z5ZEsyVkROTmpFX0xtdGU1bUhOWXpoRjNRT2FieGlFOWI1RF9FVFVwMkxja2pmLWdUN2M4SDhac2FLeW1UY1hrRXZZMjRQ?oc=5", "source_name": "Kalkine", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Limited (TLX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPdEtpSkstMmZHaXJ6OG1Hck9UMlhaYnpSQWVfSERfd3RneC01MFlyNF84a0FVZnRYWEpnWXZiWUN4bnhCQzlEMHdhdzhURkFQT1M4d0FjaGN6M1RMZ0dHR094T3RMc1R3NjVxQXdCSjR0ekRnMTRzUDkySTlSRG04YkNmencxbTZBQjJDMVJFTzNyZ0RHT1E3UHBsYXhCaG1PWTdzUm9zcnpabXZEQ2VwVTFoWW9qaDhLUkhWSDJNenRsZWs?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (TLX) 46th Annual William Blair Growth Stock Conference Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOeW5MYnMyVTc2dmpDSDBZWlU2S3dxNjBKMW9iQlZxcEhocEZUdER4ZEVJTF9CXzRZeklldmx1Q3BoQXpiYXVaSUkwRjZUdV84NVpnaXB5WW9xZEVxU01teGtvRlFFV3R1QlF6c05Vb0d0emZFODNqRTM4VjJjbHBINGo2WC1mOFYxRTVNT2J2VkQ5UkxOU2VQdTJVRTFROFdIcDM5ZEk3WWJzemVvdUtFS3FCcXdBMWp3cFE?oc=5", "source_name": "Quartr", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Shares Given Aggressive Price Target, as New Bull Emerges", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRjJOci1zR3ZZTW9lYVZJLVVFd09aUlhMN0J4ZG5GTmRSODV2X1dNMDNsaUpGUGMxVS1Ldkd0Mnh1U3dEaWdCRHJLNU9RakJEZFVtaVNqRmtnQmNQSmVWYXdidGZOTjh5emJ3TVFZMW9mZDRyQjdUUkUwR2tDMGtQRzdMeGwyLTVKT3BaNWFiNXdxX0EzWF9kaTdLWWtVTnM0Q3hOZGVUQ2RYZjg?oc=5", "source_name": "thebull.com.au", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI-enhanced cancer scans: Telix and United Imaging team up on theranostics", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPcjVnQUxkTXRlUEhZdHFSNmtmYjhFYzJFOVJCcHBBdTZVT3FiXzY5TS02eklvVk9CWktCME4yakpzcUQ5X1l0MTU0Z3R6Y1hFeVYxV08tNEhjczU1cG5zWFI2SGhuWDcxcDI1OWtfY2RVbXNaX2N4dWY3RktHMlg5NnNkWU5lRzJlVFFoV1VSdWJfRlRUOTNhcXBNNHhrdjRWYnZ2c0hFWTZKVElhV09j?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What does a takeover in the US tell us about the value of Telix shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPbkctZkhUNUdQd0Zvc0J3anhnM3RrVTRDLTY3S3hmNjlsbUhfNF9pOWF5NkRidDZPUE5SeHdnOEZnWVVkcWEyeDY0M1NZR3d1YWpJYU1yT1JHUGFjYXRZQUhXaFNUc29ZY2hWQWdvV2N3eGpieVBsY3M2Qkh2ZWh6TnNmM1NYMmlpNTdONzB1Z2RhZ1FfWTBrR3ZPa1RRN1p0VUtXZXZkRWlSZw?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (TLX) furnishes AGM addresses, presentation and results via Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNcHBEY3NPTllmWlJ6TzdhOFNJQ2Vyc2NWVDBYUVpleUdJTkFwVzB6YjVwd2JZUGhlNHRNVkpSZC1RSWVxazFiMmR6U011ZEk0bFNFek9lZ19ZbXcxM25vZVBSUGgtaWhuRGg5YlE5dnVxMGoyMmkzOUthYVAyejIzeXAtb2F6aXRfNU9ocW9RU0VmZlAwWnZhdE52UkN1bGFEZWd5YmxXRTY5Q0JZYVl5c0FST3h1NjNKMzczUg?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Telix Pharmaceuticals (ASX:TLX) Regain Momentum Ahead of Key FDA Decision?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPZFJNR2RKVWxPQ2FIT3VYZkJlOFAxRFBpV2RJUnVsTl9Cal9GbHpXVnJCenZobWVRc3VOV3kwaURtZUlZdG40R2FWZ3daV1FMcVY0OXU2ZG5TeUZPemhFcFY1M2hDZW9Ddlk2UlRSang1dFJrUk90MUxBMVBWYm9NSGxzTDllVEljTTBIb2N1bnRmNDZuZEowaTU4enpXRHo2YVE2UVNsV2pUZjdFc29DQ196cGE5Zw?oc=5", "source_name": "Kalkine", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix (TLX) CEO boosts indirect stake with 67,935-share open-market buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQQTlrSDd3NXBJaTdGZVk4bGc4NXNrbnB1NUVzbFlYYzRaX2UwWnhYWXAyNmNVUnVyVTB1R0V1X3JBX2I2MUV3ZWJWRW9ST0xsWURiVEEzRDRYZndMYWpyS2Zfb09za3pOelVjaVJnYUhHVXpMUUxQSVJBOS1SclJZVEdpV1o4Z09jWE1zQ3dRX3ZwMEt1MjBVU0FQS0laejdCZUlETG9pMTBnSWR3T3plTWxVQkZWWDR2MFE?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Telix Pharmaceuticals Co-Founder Bought US$997k Of Shares", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (TLX): How Are Its Clinical Programs Doing?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOYkJ4eVVJQzZtaUtjSl9hcmJtVlVLU1ZHRU0zc3NJbWFZdzEwTUdGRTM4Nk1HYmtQcWZjcW5fSjlZaUp5U2d3Wk9oOS1IdjZmSTgwMHZ1bDdRNFJCSDV5dS1TcV9fZjNCVHBwaUswaktybzJuSkljdmcxRjF4T1p4dUxRV3AyV1NxVmp5QTFBWWUtOFB4X2ZVaWUzbEtVdGRKY0s4dzJXbE9Rc0gyV3BBZ0VB?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US$600M Telix Pharmaceuticals (TLX) convertible bond settlement noted", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPSzNBQjZVVE5vc0pjdEowSWxNejRFanhjR010S3pSbFpteXpQeFl0N2VuQkR1Y1NTRkc3V1g5bUpWaXNJekJrVnJrQ3NnRTNUbWN4RnVrV2NHYVFQRy1aNm5uRlA5NGpiQnFFUTJJenVqSGl3TVBucVJ4cHRuaUNNcHA4UkQyekZxUzJMMUNyRVVJQ1ZnMzZtRDlQYzd6OEJBbHB1WjdYTm5kNVlWZkxLdUtXVDVKdm1vakRLOQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Becomes Most Shorted ASX Stock as of April 15, ASIC Data Shows", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNMGRTeDQ2R3NiaTZHSjhTbmpvNWJVM0RPenFoaGU2ZlBQT0V1TGlnZUphS2VPXzRiZXNJQkdWWV8wRmhlMWZ4bFJLZjdrS2RhYVkxXzNoZkZGc1VsYUdyWFdXNUpyV2k5QWxjNWRfSEJiSi05bVpFTjVMaktHOTZnaEltVy10Z3NCYVFFeEMwYVVCcXFaOEhBekRCRzVUVGJ3TGdGZV9nZjgwUQ?oc=5", "source_name": "Moomoo", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] Telix Pharmaceuticals Ltd Current Report (Foreign Issuer) | TLX SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOblhHZ0lpNHMzaDlaV3VoRmp4UjJ6ak9wWWJhLVBpN2NiMUFfNVg2OV9Oa2swTG44dmVuODFqWmdBQVFjS0FDR0F5bFNXWkFheWhiZTdsMEtrUVFiLTlUeFpIemRIMF9JVi00TWEzZkxYRzdtcHdGamhhUF9TM3BwVlE0OXhaeGZwajRfaHBpVUhHZlU0emF6bFVQMzdDc2N5S2FsSjFaaldrc1phMVlDS3k4V1pQNDRmdno5RQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Refinances Convertible Bonds", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPdzlla0lvbkp3eXVTd1lqQ1dZb3N5andYSVBTUm5EcjhaOVpMVTU2TDFKWmxWbmFEUGR1bG1Ia1BISkY5dTlJb2k1dW9lNTh5ZEpDUmxCdHlVbVJ5SDcxV2hDSTU3MmRFUEx4WFA4Z1FNQzRDckZwd1FUZUdRVWtIcnRTamNhUEdfVXotbGZfU1pXSkxXT0tYZXA0Zw?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Telix Pharmaceuticals (ASX:TLX) Valuation After Recent Share Price Moves", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPWTh2Y3hwd1VOVXVONlhleVA2YzZROVJYWFJKaUZMcHZ1bVhNYVFFVldoVWptdno2VDluREJrLTlNX0VmbUpCVG5BaWduMzVuT3IzR2hETFhuRTAzRzF1bFRMTm1tdnlhcGJvb3FLaW94d3R1eXFkaUQ5NWFVcm9BY180d25FaW9sbzVFSk1QRlZBeE45ZldsOEg0dXotMDRw?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Telix Pharmaceuticals (ASX:TLX) a Good Investment? Share Price Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPNGJhLVRyU3pTSURoN1NVZDVrQUl3d1ptRDJUQUZ4YU1xU1V0X2F6SVdpYVNhWUdpX2ZZZ1dGMHRRTmQ5SlhXb0NIQWpjLTRQbkFzcXpZTHNHMUg1c04tYjh0a2tSWUYxYU9kODVXX2pNcEZkSGRUMUhzSVNKTDRaQmhXOE0yazVlLW1SblNhbzRoaFRhZmJTeWZjOHhjY0JpbEl4UTZWM2R2blQz?oc=5", "source_name": "Kalkine", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock of the day: Telix Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOTUFZSWxDT3VVZG9faUE0WmtrSGQxS3VJQTB3cFpGYmpFODI3Rmoyc3puN1c1a3E0N1l1bk41clB6Y0hPZkFkLUV1eTEyRGNsWlVMZnRwVkVia2Q4d0lVaE9ibm9FbGdTWkFmZTRvdnFmWnVERklsaFJuZ1NBNzJ4NmdvR2VVWEZhNDRJVF9iQ3dGN1k?oc=5", "source_name": "ig.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Shares Rebound; Telix Says First Part of Phase Three Study Confirms Safety Profile of Drug Candidate", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNVVdGdlkwZDJ1ZldXSHZnTmhpMUJfbWN1a3U5b1ZxajhZRFduamY4T21BQi1MTUlKVlc2bzJManJ1bmNGWWRrYmZld0l3T2JTNmZrTENIMTNtZjVrTHNuM2I0QUFuVVhWaWQtbWE3NlZlVzlJUUs2T3BFVE9iaEtjbUFLajQ4dGgzaDFMYXhB?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Telix Pharmaceuticals (ASX:TLX) Valuation After Recent Share Price Volatility", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPanNBN18xNUdpSExIMUp2azlWOUR6ZmFCalNzbkluUDhZNE82TXlXaVUzQklidXlrYmhJeVFpc1pBLUNqXzNmTnJiWjlXckpJNHV5RXFhSXBQZU50V01Cc2lOR19seVFPdXBCUG5Vd0RacjA5WEZ6dGZkdnR1M2Jhd1FWUTEyZlpZZVc5UzdB?oc=5", "source_name": "Market source", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Telix Pharmaceuticals (ASX:TLX) Is Up 19.1% After 2026 Guidance, Shelf Filing And TLX101-Px Milestone \u2013 And What's Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPdEJsZWViLVVXRWE0WlZtT0lMSHRUY2dvaGhWeVI3cENsWnBaSmdUZmdQbVZCWi1McXIxYWIwVDRKSW1iT29OZlJsREd2MmI5VHpoZm5pN3FOdzZMTzktSnhteTJzaXVyQXNPcXQzNTJ0S05oM3JHa2traGltbDRua3k4ajgtdw?oc=5", "source_name": "Market source", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Stock Jumps 15% After Earnings. Here\u2019s What Gozellix-Driven Growth Means for 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNTDVqVHZVRGdMeGhPMmU4cTJac1NxdEhlSTRUaTAtRFdCS3JkNjZfb3c4VzZjWnB4VDdzZUNrdThWY3ZDb2tLeW01U1BycERWZXdjMUFfMHdhSlBQMnJYZThkM1pZTXNvTkQxNmNMVmU1cGFwaXpwcGR5REs2WmFsLW1TMXNkV3VseEJVekM1aThuYmIxV2lkWEVobUE0UmRJQnJUTk9qZXVESzkyZzM1WXNrdFBKOG1kVVVTVlozXzRnMXZu?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-21T08:00:00+00:00", "published_display": "21 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Telix Pharmaceuticals (ASX:TLX) Pricing Overreacting To Last Year\u2019s 56.8% Share Price Drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQbExvZXdRNGJCWHN5eXUtRkItcUl5dWs2ZE50eU9nRVF0cnF1OFJ2Vkw3aGowSThuVmJzblBEOFhsZHRlTWx4dGJvX29CbGZ6WWRuSWRnT25URktKcmY0RG9Dd1hXUGtuTzAybjNwVHJWWHk5Mjl5UmRiWVY2Q3dkSXhleW1JZU9xbUg0?oc=5", "source_name": "Market source", "published_at": "2026-01-18T08:00:00+00:00", "published_display": "18 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s What Analysts Think About Telix Pharmaceuticals (TLX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQZTQ2UDVzbUxYVnpVNUthYXNwc3hNN3o3TDhteXUxTEktbnpfcTlSanl6X2EyWHJXSl93T1pOVmE2T2ZVcnR3aEVYenIzTklIZzVuQV9HNks3LUg1YnFuWjdfUUtuWnNGODR5MTEyQ3dSa0pmSXZiNE0tdV9JampBeGpNS1JDMlJLNHMxSWtqVQ?oc=5", "source_name": "Market source", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Market Doesn't Like What It Sees From Telix Pharmaceuticals Limited's (ASX:TLX) Revenues Yet As Shares Tumble 26%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-31T08:00:00+00:00", "published_display": "31 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Class action lawsuit claims imaging agent developer Telix Pharmaceuticals misled investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPR3ZKUVdYTVV0a1dvSlVtZjhiSzBFTktlNzEzdmhQb1ZaTXRsazh4c0N5LVpJcnZpZ1pyRDZ2LVE4TWktR2F2RWxfTkRWQ01QODJURDRoOGVOQ0dWTkhkdUxidHNYQlFrcWI5N3ExOWlUTjExRmRMcERCcm9oYUhMLVF2bGEwazJUMHppbEZjNF9DalpnTklINWkxa3p2b2FWa3hyN0NqX1JFYUVUQ0swVzhLRHRHUDVEQVhIM2tVdWRGdEpBdFBHZ3dWcmNxcGdBeU5oTGVNUlMycEJMaE11bC1qM3M0VDFxelNVTkxXZkc1dw?oc=5", "source_name": "Radiology Business", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Limited's (ASX:TLX) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOT2xMMEgzSkRpVE5aRk10ckZXUDQ5cGZYLXNrbFB6bl9MWnBoUXBrbGFoZnR3dy1Xc09HanVERk1rRDMyWk5JN3Y2cWhxMUQzZmwyQkVNb0RmckpoNWQ3N1JWYm1fbllYRTVYRG9meE51cEpwQk02YTRiOEhxa3Q1N3U4NGpyNDNiaGxYQQ?oc=5", "source_name": "Market source", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Is Telix Pharmaceuticals (ASX:TLX) the ASX Mid-Cap Health Leader?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPT3dwZklSTXJqNUd2YW9mOXM2d0taMXQyU3JYdHd5TWI1TzNMN0VWbUVfSDNZMnFfZEpHWnMxOE1RTVktQlUxS3NOMUdOdHVWcUpjaHdfcHoyMlotZ283eXp1bXhhRk53QlVSdk9rUy1yTUd0RmN6ZDlXNG9pSEJQcjlNVjF1M0tRZEN2T2k3TWMxbHFwYU9PUTVYY2p0eU9sSGg4SmdR?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-22T06:42:00+00:00", "published_display": "22 Jun 2026 06:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Telix (ASX:TLX) Using Theranostic Alliances To Deepen Its Neuro-Oncology Moat?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-21T09:23:45+00:00", "published_display": "21 Jun 2026 09:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (TLX), United Imaging Healthcare Form Strategic Theranostics Research Partnership", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Insider Monkey", "published_at": "2026-06-17T19:43:19+00:00", "published_display": "17 Jun 2026 19:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Limited Stock 12\u2011Month Price Target Raised to $17.27, Implies 80% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTDRkMXVMTzRlcW1YSnMyMDI3ZGpRTWNJejc0UXNwTGVDN04yWURiTmpsaTlLWHB1NGxNTHFLaU5wRVNqY2RNWktpWHl1TllaODdpRjJFWEI1a0hPTjBvd3N3aU8xUzJwUEQ3bldyeEFlTF9XZmdQVTJIWHFTWEFKa0dVY3lpc0NEX25EMkJpNlNlYkNXcjRsdDF1LUdLaXBnSWhmMTcwSlFfeVAzU05BcktGbHVVMzZRYk1STTRwbTJGeGVVdXpLd0hpQzNqd2h2RVZCTnA4V3VCNmd1RmJsOWpINVo1RHFP?oc=5", "source_name": "TradingView", "published_at": "2026-06-17T04:20:00+00:00", "published_display": "17 Jun 2026 04:20", "sentiment": "positive", "sentiment_pct": 80, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (ASX:TLX) Shares Valuation After New Theranostics Collaboration With United Imaging", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-16T00:32:53+00:00", "published_display": "16 Jun 2026 00:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Prediction: I think Telix shares could double in value in 2026. Here\u2019s why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNZmRVcnhSbmJLQVVtN2dSX2FvemtLS0hRTVNiMDFxVVlwcDRrMXIxbDZEMFNtTk11djlTSnVtOUQxM3dfSXBwU01vRXVsb2tnWEtFRllUa09WNi1DT1N5VEx4dDhxNndzVkJhVnJVX3JtcElQU3hqdmxTQ3ZiYXVHckhLVUZMYmhfUkFFdUZiYS1NWWhVSE1kZU82cGtsYmRfWUJrVFpTX3NJUGM?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (ASX:TLX): Is This ASX Biotech Stock a Buy Opportunity", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPcEwzaFlTZ19yUkx2OVJMYVlNQzdtSVNWZTdsLWxTV3dMNk5WTkFETlNoaDFGaXFZSjR2SWFYN2JIV3FkUG5WOWhmbzVGalZVbTJIdmlhdWwyQWF5QlBmYjZuUUdBX0Z5ZEsyVkROTmpFX0xtdGU1bUhOWXpoRjNRT2FieGlFOWI1RF9FVFVwMkxja2pmLWdUN2M4SDhac2FLeW1UY1hrRXZZMjRQ?oc=5", "source_name": "Kalkine", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Limited (TLX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPdEtpSkstMmZHaXJ6OG1Hck9UMlhaYnpSQWVfSERfd3RneC01MFlyNF84a0FVZnRYWEpnWXZiWUN4bnhCQzlEMHdhdzhURkFQT1M4d0FjaGN6M1RMZ0dHR094T3RMc1R3NjVxQXdCSjR0ekRnMTRzUDkySTlSRG04YkNmencxbTZBQjJDMVJFTzNyZ0RHT1E3UHBsYXhCaG1PWTdzUm9zcnpabXZEQ2VwVTFoWW9qaDhLUkhWSDJNenRsZWs?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (TLX) 46th Annual William Blair Growth Stock Conference Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOeW5MYnMyVTc2dmpDSDBZWlU2S3dxNjBKMW9iQlZxcEhocEZUdER4ZEVJTF9CXzRZeklldmx1Q3BoQXpiYXVaSUkwRjZUdV84NVpnaXB5WW9xZEVxU01teGtvRlFFV3R1QlF6c05Vb0d0emZFODNqRTM4VjJjbHBINGo2WC1mOFYxRTVNT2J2VkQ5UkxOU2VQdTJVRTFROFdIcDM5ZEk3WWJzemVvdUtFS3FCcXdBMWp3cFE?oc=5", "source_name": "Quartr", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Shares Given Aggressive Price Target, as New Bull Emerges", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRjJOci1zR3ZZTW9lYVZJLVVFd09aUlhMN0J4ZG5GTmRSODV2X1dNMDNsaUpGUGMxVS1Ldkd0Mnh1U3dEaWdCRHJLNU9RakJEZFVtaVNqRmtnQmNQSmVWYXdidGZOTjh5emJ3TVFZMW9mZDRyQjdUUkUwR2tDMGtQRzdMeGwyLTVKT3BaNWFiNXdxX0EzWF9kaTdLWWtVTnM0Q3hOZGVUQ2RYZjg?oc=5", "source_name": "thebull.com.au", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI-enhanced cancer scans: Telix and United Imaging team up on theranostics", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPcjVnQUxkTXRlUEhZdHFSNmtmYjhFYzJFOVJCcHBBdTZVT3FiXzY5TS02eklvVk9CWktCME4yakpzcUQ5X1l0MTU0Z3R6Y1hFeVYxV08tNEhjczU1cG5zWFI2SGhuWDcxcDI1OWtfY2RVbXNaX2N4dWY3RktHMlg5NnNkWU5lRzJlVFFoV1VSdWJfRlRUOTNhcXBNNHhrdjRWYnZ2c0hFWTZKVElhV09j?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What does a takeover in the US tell us about the value of Telix shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPbkctZkhUNUdQd0Zvc0J3anhnM3RrVTRDLTY3S3hmNjlsbUhfNF9pOWF5NkRidDZPUE5SeHdnOEZnWVVkcWEyeDY0M1NZR3d1YWpJYU1yT1JHUGFjYXRZQUhXaFNUc29ZY2hWQWdvV2N3eGpieVBsY3M2Qkh2ZWh6TnNmM1NYMmlpNTdONzB1Z2RhZ1FfWTBrR3ZPa1RRN1p0VUtXZXZkRWlSZw?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (TLX) furnishes AGM addresses, presentation and results via Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNcHBEY3NPTllmWlJ6TzdhOFNJQ2Vyc2NWVDBYUVpleUdJTkFwVzB6YjVwd2JZUGhlNHRNVkpSZC1RSWVxazFiMmR6U011ZEk0bFNFek9lZ19ZbXcxM25vZVBSUGgtaWhuRGg5YlE5dnVxMGoyMmkzOUthYVAyejIzeXAtb2F6aXRfNU9ocW9RU0VmZlAwWnZhdE52UkN1bGFEZWd5YmxXRTY5Q0JZYVl5c0FST3h1NjNKMzczUg?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Telix Pharmaceuticals (ASX:TLX) Regain Momentum Ahead of Key FDA Decision?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPZFJNR2RKVWxPQ2FIT3VYZkJlOFAxRFBpV2RJUnVsTl9Cal9GbHpXVnJCenZobWVRc3VOV3kwaURtZUlZdG40R2FWZ3daV1FMcVY0OXU2ZG5TeUZPemhFcFY1M2hDZW9Ddlk2UlRSang1dFJrUk90MUxBMVBWYm9NSGxzTDllVEljTTBIb2N1bnRmNDZuZEowaTU4enpXRHo2YVE2UVNsV2pUZjdFc29DQ196cGE5Zw?oc=5", "source_name": "Kalkine", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix (TLX) CEO boosts indirect stake with 67,935-share open-market buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQQTlrSDd3NXBJaTdGZVk4bGc4NXNrbnB1NUVzbFlYYzRaX2UwWnhYWXAyNmNVUnVyVTB1R0V1X3JBX2I2MUV3ZWJWRW9ST0xsWURiVEEzRDRYZndMYWpyS2Zfb09za3pOelVjaVJnYUhHVXpMUUxQSVJBOS1SclJZVEdpV1o4Z09jWE1zQ3dRX3ZwMEt1MjBVU0FQS0laejdCZUlETG9pMTBnSWR3T3plTWxVQkZWWDR2MFE?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Telix Pharmaceuticals Co-Founder Bought US$997k Of Shares", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals (TLX): How Are Its Clinical Programs Doing?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOYkJ4eVVJQzZtaUtjSl9hcmJtVlVLU1ZHRU0zc3NJbWFZdzEwTUdGRTM4Nk1HYmtQcWZjcW5fSjlZaUp5U2d3Wk9oOS1IdjZmSTgwMHZ1bDdRNFJCSDV5dS1TcV9fZjNCVHBwaUswaktybzJuSkljdmcxRjF4T1p4dUxRV3AyV1NxVmp5QTFBWWUtOFB4X2ZVaWUzbEtVdGRKY0s4dzJXbE9Rc0gyV3BBZ0VB?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US$600M Telix Pharmaceuticals (TLX) convertible bond settlement noted", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPSzNBQjZVVE5vc0pjdEowSWxNejRFanhjR010S3pSbFpteXpQeFl0N2VuQkR1Y1NTRkc3V1g5bUpWaXNJekJrVnJrQ3NnRTNUbWN4RnVrV2NHYVFQRy1aNm5uRlA5NGpiQnFFUTJJenVqSGl3TVBucVJ4cHRuaUNNcHA4UkQyekZxUzJMMUNyRVVJQ1ZnMzZtRDlQYzd6OEJBbHB1WjdYTm5kNVlWZkxLdUtXVDVKdm1vakRLOQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Becomes Most Shorted ASX Stock as of April 15, ASIC Data Shows", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNMGRTeDQ2R3NiaTZHSjhTbmpvNWJVM0RPenFoaGU2ZlBQT0V1TGlnZUphS2VPXzRiZXNJQkdWWV8wRmhlMWZ4bFJLZjdrS2RhYVkxXzNoZkZGc1VsYUdyWFdXNUpyV2k5QWxjNWRfSEJiSi05bVpFTjVMaktHOTZnaEltVy10Z3NCYVFFeEMwYVVCcXFaOEhBekRCRzVUVGJ3TGdGZV9nZjgwUQ?oc=5", "source_name": "Moomoo", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] Telix Pharmaceuticals Ltd Current Report (Foreign Issuer) | TLX SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOblhHZ0lpNHMzaDlaV3VoRmp4UjJ6ak9wWWJhLVBpN2NiMUFfNVg2OV9Oa2swTG44dmVuODFqWmdBQVFjS0FDR0F5bFNXWkFheWhiZTdsMEtrUVFiLTlUeFpIemRIMF9JVi00TWEzZkxYRzdtcHdGamhhUF9TM3BwVlE0OXhaeGZwajRfaHBpVUhHZlU0emF6bFVQMzdDc2N5S2FsSjFaaldrc1phMVlDS3k4V1pQNDRmdno5RQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Refinances Convertible Bonds", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPdzlla0lvbkp3eXVTd1lqQ1dZb3N5andYSVBTUm5EcjhaOVpMVTU2TDFKWmxWbmFEUGR1bG1Ia1BISkY5dTlJb2k1dW9lNTh5ZEpDUmxCdHlVbVJ5SDcxV2hDSTU3MmRFUEx4WFA4Z1FNQzRDckZwd1FUZUdRVWtIcnRTamNhUEdfVXotbGZfU1pXSkxXT0tYZXA0Zw?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Telix Pharmaceuticals (ASX:TLX) Valuation After Recent Share Price Moves", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPWTh2Y3hwd1VOVXVONlhleVA2YzZROVJYWFJKaUZMcHZ1bVhNYVFFVldoVWptdno2VDluREJrLTlNX0VmbUpCVG5BaWduMzVuT3IzR2hETFhuRTAzRzF1bFRMTm1tdnlhcGJvb3FLaW94d3R1eXFkaUQ5NWFVcm9BY180d25FaW9sbzVFSk1QRlZBeE45ZldsOEg0dXotMDRw?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Telix Pharmaceuticals (ASX:TLX) a Good Investment? Share Price Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPNGJhLVRyU3pTSURoN1NVZDVrQUl3d1ptRDJUQUZ4YU1xU1V0X2F6SVdpYVNhWUdpX2ZZZ1dGMHRRTmQ5SlhXb0NIQWpjLTRQbkFzcXpZTHNHMUg1c04tYjh0a2tSWUYxYU9kODVXX2pNcEZkSGRUMUhzSVNKTDRaQmhXOE0yazVlLW1SblNhbzRoaFRhZmJTeWZjOHhjY0JpbEl4UTZWM2R2blQz?oc=5", "source_name": "Kalkine", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock of the day: Telix Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOTUFZSWxDT3VVZG9faUE0WmtrSGQxS3VJQTB3cFpGYmpFODI3Rmoyc3puN1c1a3E0N1l1bk41clB6Y0hPZkFkLUV1eTEyRGNsWlVMZnRwVkVia2Q4d0lVaE9ibm9FbGdTWkFmZTRvdnFmWnVERklsaFJuZ1NBNzJ4NmdvR2VVWEZhNDRJVF9iQ3dGN1k?oc=5", "source_name": "ig.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Shares Rebound; Telix Says First Part of Phase Three Study Confirms Safety Profile of Drug Candidate", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNVVdGdlkwZDJ1ZldXSHZnTmhpMUJfbWN1a3U5b1ZxajhZRFduamY4T21BQi1MTUlKVlc2bzJManJ1bmNGWWRrYmZld0l3T2JTNmZrTENIMTNtZjVrTHNuM2I0QUFuVVhWaWQtbWE3NlZlVzlJUUs2T3BFVE9iaEtjbUFLajQ4dGgzaDFMYXhB?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Telix Pharmaceuticals (ASX:TLX) Valuation After Recent Share Price Volatility", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPanNBN18xNUdpSExIMUp2azlWOUR6ZmFCalNzbkluUDhZNE82TXlXaVUzQklidXlrYmhJeVFpc1pBLUNqXzNmTnJiWjlXckpJNHV5RXFhSXBQZU50V01Cc2lOR19seVFPdXBCUG5Vd0RacjA5WEZ6dGZkdnR1M2Jhd1FWUTEyZlpZZVc5UzdB?oc=5", "source_name": "Market source", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Telix Pharmaceuticals (ASX:TLX) Is Up 19.1% After 2026 Guidance, Shelf Filing And TLX101-Px Milestone \u2013 And What's Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPdEJsZWViLVVXRWE0WlZtT0lMSHRUY2dvaGhWeVI3cENsWnBaSmdUZmdQbVZCWi1McXIxYWIwVDRKSW1iT29OZlJsREd2MmI5VHpoZm5pN3FOdzZMTzktSnhteTJzaXVyQXNPcXQzNTJ0S05oM3JHa2traGltbDRua3k4ajgtdw?oc=5", "source_name": "Market source", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Stock Jumps 15% After Earnings. Here\u2019s What Gozellix-Driven Growth Means for 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNTDVqVHZVRGdMeGhPMmU4cTJac1NxdEhlSTRUaTAtRFdCS3JkNjZfb3c4VzZjWnB4VDdzZUNrdThWY3ZDb2tLeW01U1BycERWZXdjMUFfMHdhSlBQMnJYZThkM1pZTXNvTkQxNmNMVmU1cGFwaXpwcGR5REs2WmFsLW1TMXNkV3VseEJVekM1aThuYmIxV2lkWEVobUE0UmRJQnJUTk9qZXVESzkyZzM1WXNrdFBKOG1kVVVTVlozXzRnMXZu?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-21T08:00:00+00:00", "published_display": "21 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Telix Pharmaceuticals (ASX:TLX) Pricing Overreacting To Last Year\u2019s 56.8% Share Price Drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQbExvZXdRNGJCWHN5eXUtRkItcUl5dWs2ZE50eU9nRVF0cnF1OFJ2Vkw3aGowSThuVmJzblBEOFhsZHRlTWx4dGJvX29CbGZ6WWRuSWRnT25URktKcmY0RG9Dd1hXUGtuTzAybjNwVHJWWHk5Mjl5UmRiWVY2Q3dkSXhleW1JZU9xbUg0?oc=5", "source_name": "Market source", "published_at": "2026-01-18T08:00:00+00:00", "published_display": "18 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s What Analysts Think About Telix Pharmaceuticals (TLX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQZTQ2UDVzbUxYVnpVNUthYXNwc3hNN3o3TDhteXUxTEktbnpfcTlSanl6X2EyWHJXSl93T1pOVmE2T2ZVcnR3aEVYenIzTklIZzVuQV9HNks3LUg1YnFuWjdfUUtuWnNGODR5MTEyQ3dSa0pmSXZiNE0tdV9JampBeGpNS1JDMlJLNHMxSWtqVQ?oc=5", "source_name": "Market source", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Market Doesn't Like What It Sees From Telix Pharmaceuticals Limited's (ASX:TLX) Revenues Yet As Shares Tumble 26%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-31T08:00:00+00:00", "published_display": "31 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Class action lawsuit claims imaging agent developer Telix Pharmaceuticals misled investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPR3ZKUVdYTVV0a1dvSlVtZjhiSzBFTktlNzEzdmhQb1ZaTXRsazh4c0N5LVpJcnZpZ1pyRDZ2LVE4TWktR2F2RWxfTkRWQ01QODJURDRoOGVOQ0dWTkhkdUxidHNYQlFrcWI5N3ExOWlUTjExRmRMcERCcm9oYUhMLVF2bGEwazJUMHppbEZjNF9DalpnTklINWkxa3p2b2FWa3hyN0NqX1JFYUVUQ0swVzhLRHRHUDVEQVhIM2tVdWRGdEpBdFBHZ3dWcmNxcGdBeU5oTGVNUlMycEJMaE11bC1qM3M0VDFxelNVTkxXZkc1dw?oc=5", "source_name": "Radiology Business", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix Pharmaceuticals Limited's (ASX:TLX) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOT2xMMEgzSkRpVE5aRk10ckZXUDQ5cGZYLXNrbFB6bl9MWnBoUXBrbGFoZnR3dy1Xc09HanVERk1rRDMyWk5JN3Y2cWhxMUQzZmwyQkVNb0RmckpoNWQ3N1JWYm1fbllYRTVYRG9meE51cEpwQk02YTRiOEhxa3Q1N3U4NGpyNDNiaGxYQQ?oc=5", "source_name": "Market source", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 75, "total_relevant": 33, "sentiment_summary": {"positive": 6, "negative": 1, "neutral": 26, "score": 53, "total": 33, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 13.55, "count": 24}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 14.5, "latest_week": "2026-06-19", "one_week_move": 6.6, "four_week_move": 8.9, "twelve_week_move": 6.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.459959, "market_dynamics_buy_signal": false, "relative_strength": -2.514357, "fair_value_gap": -13.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 52.2051, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+6.6% over one week, +8.9% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 8}, {"label": "Stock Titan", "count": 5}, {"label": "simplywall.st", "count": 4}, {"label": "Kalkine", "count": 3}, {"label": "The Motley Fool Australia", "count": 2}, {"label": "Kalkine Media", "count": 1}, {"label": "Insider Monkey", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 33}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 24}, {"label": "Deals and strategy", "count": 2}, {"label": "Analyst action", "count": 2}, {"label": "Earnings", "count": 2}, {"label": "Guidance", "count": 2}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "33", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+6.6% over one week, +8.9% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Is Telix Pharmaceuticals (ASX:TLX) the ASX Mid-Cap Health Leader?"}], "updated_at": "2026-06-22T19:49:04.594613+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}